PADI4 and non-small cell lung carcinoma: It is reported that cell free circulation PADI4 mRNA level (together with cfDNA, PPBP, and haptoglobin) in peripheral blood of non-small cell lung cancer patients was significantly higher than that in healthy donors, so PADI4 may serve as a potential marker for NSCLC diagnosis (Ulivi et al., 2013).